263 related articles for article (PubMed ID: 11987155)
41. Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?
Schimming R; Reusch P; Kuschnierz J; Schmelzeisen R
J Craniomaxillofac Surg; 2004 Jun; 32(3):176-81. PubMed ID: 15113577
[TBL] [Abstract][Full Text] [Related]
42. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.
Fonsatti E; Sigalotti L; Arslan P; Altomonte M; Maio M
Curr Cancer Drug Targets; 2003 Dec; 3(6):427-32. PubMed ID: 14683500
[TBL] [Abstract][Full Text] [Related]
43. Endoglin (CD105) expression in human renal cell carcinoma.
Sandlund J; Hedberg Y; Bergh A; Grankvist K; Ljungberg B; Rasmuson T
BJU Int; 2006 Apr; 97(4):706-10. PubMed ID: 16536758
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
45. Endoglin expression as a measure of microvessel density in cervical cancer.
Brewer CA; Setterdahl JJ; Li MJ; Johnston JM; Mann JL; McAsey ME
Obstet Gynecol; 2000 Aug; 96(2):224-8. PubMed ID: 10908767
[TBL] [Abstract][Full Text] [Related]
46. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
[TBL] [Abstract][Full Text] [Related]
47. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
[TBL] [Abstract][Full Text] [Related]
48. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers.
Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
Pathol Int; 2006 Dec; 56(12):717-23. PubMed ID: 17096728
[TBL] [Abstract][Full Text] [Related]
49. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
50. Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement.
Miyata Y; Sakai H
Int J Urol; 2015 Sep; 22(9):806-15. PubMed ID: 26153072
[TBL] [Abstract][Full Text] [Related]
51. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
[TBL] [Abstract][Full Text] [Related]
52. Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
Pappa CA; Alexandrakis MG; Boula A; Psarakis FE; Kolovou A; Bantouna V; Stavroulaki E; Tsirakis G
Hematol Oncol; 2013 Dec; 31(4):201-5. PubMed ID: 23576184
[TBL] [Abstract][Full Text] [Related]
53. mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer.
Gómez-Esquer F; Agudo D; Martínez-Arribas F; Nuñez-Villar MJ; Schneider J
Anticancer Res; 2004; 24(3a):1581-5. PubMed ID: 15274325
[TBL] [Abstract][Full Text] [Related]
54. Endoglin (CD105): a target for anti-angiogenetic cancer therapy.
Fonsatti E; Altomonte M; Arslan P; Maio M
Curr Drug Targets; 2003 May; 4(4):291-6. PubMed ID: 12699349
[TBL] [Abstract][Full Text] [Related]
55. The prognostic value of endoglin (CD105) expression in ovarian carcinoma.
Taskiran C; Erdem O; Onan A; Arisoy O; Acar A; Vural C; Erdem M; Ataoglu O; Guner H
Int J Gynecol Cancer; 2006; 16(5):1789-93. PubMed ID: 17009973
[TBL] [Abstract][Full Text] [Related]
56. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.
Marioni G; Marino F; Giacomelli L; Staffieri C; Mariuzzi ML; Violino E; De Filippis C
Acta Otolaryngol; 2006 Jun; 126(6):633-9. PubMed ID: 16720449
[TBL] [Abstract][Full Text] [Related]
57. Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer.
Lind AJ; Wikström P; Granfors T; Egevad L; Stattin P; Bergh A
Prostate; 2005 Mar; 62(4):394-9. PubMed ID: 15378518
[TBL] [Abstract][Full Text] [Related]
58. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
59. Endoglin as a marker in cervical paragangliomas.
Eleno N; Düwel A; Muñoz A; Paz-Bouza J; López-Novoa JM; Lozano F
Head Neck; 2010 Jun; 32(6):737-43. PubMed ID: 19827102
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer.
Kitamura K; Kasuya K; Tsuchida A; Mimuro A; Inoue K; Aoki T; Aoki T; Koyanagi Y
Oncol Rep; 2003; 10(2):327-32. PubMed ID: 12579267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
